Researchers from the University of Illinois, Stanford University and others will discuss in the journal of Pharmacotherapy next month the practice of prescribing medications for other purposes than those approved for by the FDA, the so called “off-label use”, which is sometimes encouraged by manufacturers. The researchers have identified 14 such medications, most of them psychiatric drugs, and call for an investigation of off-label uses for prescription medications and their potential safety hazards.